Cargando…

625. The Hidden Cost of Dalbavancin: OPAT-RN Time Spent on Coordination for Patients with Substance Use Disorder

BACKGROUND: The use of dalbavancin (DAL) enhances the management of serious gram-positive infections in people with substance use disorder (SUD) by eliminating the need for central lines, weekly lab monitoring, and may decrease length of hospitalizations. Though administered weekly, care coordinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglass, Alyse, Mayer, Heather, Young, Kathleen, Streifel, Amber C, Makadia, Jina, Lewis, James, Sikka, Monica K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644415/ http://dx.doi.org/10.1093/ofid/ofab466.823

Ejemplares similares

The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs
por: Douglass, Alyse H., et al.
Publicado: (2023)

122. Dalbavancin Use in Patients with Substance Use Disorders
por: Streifel, Amber C, et al.
Publicado: (2020)

1268. Dalbavancin for the Treatment of Infections due to Staphylococcus aureus
por: Streifel, Amber C, et al.
Publicado: (2020)

1762. A Review of Antibiotic Outcomes Data Utilizing the Multidisciplinary OPTIONS-DC Conference for PWUD
por: Douglass, Alyse H, et al.
Publicado: (2022)

1028. Dalbavancin Use in Complicated Infections and-associated Cost-Savings
por: Streifel, Amber C, et al.
Publicado: (2019)

1004. Dalbavancin Use and Associated Cost-Savings: An Update
por: Streifel, Amber C, et al.
Publicado: (2022)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

757 Comparison of Nephrotoxicity in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Beta-lactams or Vancomycin
por: Streifel, Amber, et al.
Publicado: (2014)

1829. Dalbavancin versus standard of care as directed therapy for Staphylococcus aureus bacteremia in patients unable to receive OPAT
por: Frazier, J, et al.
Publicado: (2022)

Screening for co-infections in patients with substance use disorders and severe bacterial infections
por: Varley, Cara D., et al.
Publicado: (2022)

742. The Development, Implementation, and Feasibility of Multidisciplinary Treatment Planning Conference for Individuals with Unstable Substance Use Disorders and Active Infections Requiring Prolonged Antimicrobial Therapy: The OPTIONS-DC Model
por: Strnad, Luke, et al.
Publicado: (2019)

Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference
por: Conte, Michael, et al.
Publicado: (2022)

188. Outcomes After Implementing the OPTIONS-DC Multidisciplinary Care Conference for Patients with Substance Use Disorders and Severe Bacterial Infections
por: Schneider, Brenton J, et al.
Publicado: (2021)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

625. Sustained Efforts Improve Adherence to Monitoring for Solid Tumor Patients Discharged on Outpatient Parenteral Antimicrobial Therapy (OPAT) at a Comprehensive Cancer Center
por: Robins, Alison, et al.
Publicado: (2020)

1298 Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Means, Laura, et al.
Publicado: (2014)

Health Care Utilization Patterns for Patients With a History of Substance Use Requiring OPAT
por: Ashraf, Bilal, et al.
Publicado: (2021)

New isotope $^{227}$Rn and revised halflives for $^{223}$Rn and $^{226}$Rn
por: García-Borge, M J, et al.
Publicado: (1986)

618. Post-discharge Care Coordination Telephone Call for Patients Enrolled in the UNC OPAT Program
por: Boerneke, Renae A, et al.
Publicado: (2020)

627. Tele-OPAT Outcomes at Two Community Hospitals
por: Sheridan, Kathleen R, et al.
Publicado: (2020)

New isotope $^{227}$Rn and revised half lives for $^{223}$Rn and $^{226}$Rn
por: Nybø, K
Publicado: (1987)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

Facilitating OPAT in rural areas
por: Mehta, Meera, et al.
Publicado: (2023)

Exploring the advancements of Australian OPAT
por: Lai, Tony, et al.
Publicado: (2023)

P13 Every patient who could have OPAT, should have OPAT—the importance of data
por: Williams, Steph, et al.
Publicado: (2022)

Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program
por: Agnihotri, Gaurav, et al.
Publicado: (2023)

The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report
por: Streifel, Amber C., et al.
Publicado: (2022)

1300 OPAT Administration in the Homeless Population
por: Hernandez, Whitney, et al.
Publicado: (2014)

OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020)

339. OPAT Outcomes in Patients with Immunocompromise
por: Mahoney, Monica V, et al.
Publicado: (2023)

600. Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Agnihotri, Gaurav, et al.
Publicado: (2020)

Being ‘at-home’ on outpatient parenteral antimicrobial therapy (OPAT): a qualitative study of parents’ experiences of paediatric OPAT
por: Carter, Bernie, et al.
Publicado: (2020)

Selections on 625 Injections for Local Anesthesia
por: Polet, Maurice
Publicado: (1910)

1923. OPAT or No-PAT? Evaluation of Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Daptomycin or Ertapenem for “Ease of Administration”
por: Britt, Rachel S, et al.
Publicado: (2018)

Laser spectroscopy of $^{200}$Rn and $^{201}$Rn using $\alpha$- detection
por: Georg, U, et al.
Publicado: (1995)

592. A Pilot Program to Evaluate Home Telemedicine Visits in an OPAT Program
por: Sheridan, Kathleen R, et al.
Publicado: (2020)

Hidden GBV: Women and substance use
por: Moir, Eilidh, et al.
Publicado: (2022)

Spustenie hadrónového urýchľovača častíc opäť posunuli
Publicado: (2008)

Spustenie hadrónového urýchľovača častíc opäť posunuli
Publicado: (2008)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t10n0p6qr3sd7iv0od17mlij51